miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3'UTR of CD46.
about
Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer.Computational analysis of expression of human embryonic stem cell-associated signatures in tumors.MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1.Comprehensive analysis of microRNAs in breast cancermiR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8The nuclear import of oncoprotein hepatitis B X-interacting protein depends on interacting with c-Fos and phosphorylation of both proteins in breast cancer cells.Hepatitis B virus X protein up-regulates C4b-binding protein α through activating transcription factor Sp1 in protection of hepatoma cells from complement attack.Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520.A novel positive feedback loop involving FASN/p-ERK1/2/5-LOX/LTB4/FASN sustains high growth of breast cancer cells.Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers.microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.Selective activation of miRNAs of the primate-specific chromosome 19 miRNA cluster (C19MC) in cancer and stem cells and possible contribution to regulation of apoptosis.Regulation of Complement-Dependent Cytotoxicity by MicroRNAs miR-200b, miR-200c, and miR-217.MicroRNA-520b affects the proliferation of human glioblastoma cells by directly targeting cyclin D1.Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP.microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).Characterization of the Regulation of CD46 RNA Alternative Splicing.Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.Tissue Factor Regulation by miR-520g in Primitive Neuronal Brain Tumor Cells: A Possible Link between Oncomirs and the Vascular Tumor Microenvironment.Human liver regeneration is characterized by the coordinated expression of distinct microRNA governing cell cycle fate.The dark side of a success story: microRNAs of the C19MC cluster in human tumours.MiR-520d-3p antitumor activity in human breast cancer via post-transcriptional regulation of spindle and kinetochore associated 2 expression.Identification of chemoresistance-associated miRNAs in breast cancerMiR-520b restrains cell growth by targeting HDAC4 in lung cancer
P2860
Q30368082-53CF0C66-A541-41EB-8D52-67077489F36BQ34063075-3FCE7DC9-B849-4CF5-BB1A-C1B5A1C95BADQ34154832-B4CC66F2-6236-4679-A510-E8F4BD3F8E6CQ34529730-DF3A17A7-B10A-43A0-9A71-21E8258A63D3Q34787462-4FB96C6A-06EA-4A3B-8A8D-81B846306E31Q36967330-5D6761E4-2006-495D-BE9F-1A1A8BD2CF85Q37317472-10541A4B-7027-4DAA-AF01-12C5B757594FQ37582377-9FEAA7B9-0C9E-4B08-8822-C5CA11C0233BQ37729512-692D9DE7-CFC3-4676-B9FE-57619F279968Q38249091-1143C1D3-0F6E-4A91-A8B4-3B941F4B6C5FQ38336073-9E3E8A90-2518-449C-81EF-1D13233EFB57Q38713237-C8600606-215B-4691-BA66-245CC617C0CBQ38770633-021F5C7E-AFBE-494B-A941-C33CFCD3174CQ38809332-53AFC38D-E003-419B-B96A-692CF33E0961Q38989340-32166804-C2D9-422E-B8F8-10280E5643C1Q39137248-937F339E-B52F-49CF-98EE-5C75A7F6F8FEQ39439193-3420CFAF-F7ED-43FB-AA66-CFB411DE4B09Q40659030-82918975-68CE-48CB-AD13-912443626F80Q47165108-A1CFAC10-39BF-45BD-84D6-80727DD37941Q49122621-7E78F392-BC63-4BAF-8CA2-6BFD672F9DDEQ53117622-B63612F3-613F-4F9C-9209-526DCB5DD7A7Q54526480-4C1C5A44-E89F-48A7-A5CC-CDE93A9D1B07Q55175714-EC73FC7D-9F2C-44B7-9F88-78BAC196A5A9Q58698621-3A8D7AFB-4F0C-4EE7-81B6-95C3968E03D6Q58779543-0CB0BBE9-0BB3-4C08-8761-592E886CE894
P2860
miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3'UTR of CD46.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
miRNA-520b and miR-520e sensit ...... ectly targeting 3'UTR of CD46.
@en
miRNA-520b and miR-520e sensit ...... ectly targeting 3'UTR of CD46.
@nl
type
label
miRNA-520b and miR-520e sensit ...... ectly targeting 3'UTR of CD46.
@en
miRNA-520b and miR-520e sensit ...... ectly targeting 3'UTR of CD46.
@nl
prefLabel
miRNA-520b and miR-520e sensit ...... ectly targeting 3'UTR of CD46.
@en
miRNA-520b and miR-520e sensit ...... ectly targeting 3'UTR of CD46.
@nl
P2093
P356
P1476
miRNA-520b and miR-520e sensit ...... ectly targeting 3'UTR of CD46.
@en
P2093
Changliang Shan
Shuai Zhang
Weiying Zhang
Wenjing Cui
Xiaodong Zhang
Yiwen Zhang
P304
P356
10.4161/CBT.10.3.12277
P577
2010-08-07T00:00:00Z